Studies on blood eosinophils. II. Patients with Löffler's cardiomyopathy

Insights

Patients with hypereosinophilic states, like Löffler's endocarditis, show activated eosinophils. These cells release damaging products in circulation, contributing to restrictive cardiomyopathy and endomyocardial fibrosis.

Area of Science:

  • Cardiology
  • Hematology
  • Immunology

Background:

  • Hypereosinophilic states, including Löffler's endocarditis and endomyocardial fibrosis, are characterized by elevated eosinophil counts.
  • These conditions can lead to severe cardiac dysfunction, specifically restrictive cardiomyopathy.

Purpose of the Study:

  • To investigate the characteristics of blood eosinophils in patients with heart failure and raised eosinophil counts.
  • To explore the potential role of eosinophil degranulation in the pathogenesis of cardiac damage in these patients.

Main Methods:

  • Analysis of blood eosinophils from four patients with elevated eosinophil counts and heart failure.
  • Cardiological assessment including identification of endocardial lesions.
  • Morphological and functional characterization of patient eosinophils compared to normal controls, including receptor expression and phagocytosis assays.

Main Results:

  • Three patients exhibited endocardial lesions and restrictive cardiomyopathy consistent with Löffler's endocarditis or endomyocardial fibrosis.
  • All patients had >1 X 10(9) eosinophils/L with vacuolated cytoplasm and altered crystalloid granules.
  • Patient eosinophils displayed IgG and C3b receptors and phagocytic activity, unlike normal eosinophils.

Conclusions:

  • Circulating eosinophils in these patients exhibited characteristics of mature or stimulated cells.
  • These activated eosinophils underwent degranulation in response to blood-borne stimuli.
  • The findings support the hypothesis that sustained release of eosinophil products contributes to the restrictive cardiomyopathy seen in hypereosinophilic states.

Related Concept Videos

Imaging Studies for Cardiovascular System I:Echocardiography01:17

Imaging Studies for Cardiovascular System I:Echocardiography

Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion, evaluates...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...